AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2024

Sep 4, 2024

29831_dirs_2024-09-03_c31f0a3a-a127-4317-a34b-6a2ae0c4ec0f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2024-08-31

Reporting Person: MALIK AAMIR (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-31	Common Stock	F	20195.0000	$29.0100	Disposed	29548.0000	Direct

Footnotes

F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F2: Price is the closing price of Pfizer common stock on August 30, 2024.